menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Long-Term Aspirin Use Associated with Decreased Cancer Risk

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Related
Comments
  • In Partnership with

  • Overview

    [Read the Article]

    According to a new study, low dose aspirin taken regularly was associated with a reduced risk for cancer.

    Researchers from Massachusetts General Hospital examined data from two large national studies that include about 136,000 men and women who have been providing detailed information about their overall health for decades.

    Researchers identified 20,414 cancers among 88,084 women and 7,571 cancers among 47,881 men during a 32-year follow-up. Regular use of aspirin, two times or more per week, was associated with a 3 percent lower overall risk for cancer. This was mostly due to a 15 percent lower risk for gastrointestinal tract cancers and a 19 percent lower risk for cancers of the colon and rectum.

    [Watch more videos of The JAMA Report]

Facebook Comments

Recommended
Details
Related
Comments
  • In Partnership with

  • Overview

    [Read the Article]

    According to a new study, low dose aspirin taken regularly was associated with a reduced risk for cancer.

    Researchers from Massachusetts General Hospital examined data from two large national studies that include about 136,000 men and women who have been providing detailed information about their overall health for decades.

    Researchers identified 20,414 cancers among 88,084 women and 7,571 cancers among 47,881 men during a 32-year follow-up. Regular use of aspirin, two times or more per week, was associated with a 3 percent lower overall risk for cancer. This was mostly due to a 15 percent lower risk for gastrointestinal tract cancers and a 19 percent lower risk for cancers of the colon and rectum.

    [Watch more videos of The JAMA Report]

Facebook Comments

Schedule30 Apr 2024